Intrinsic value of Kestra Medical Technologies, Ltd. Common Stock (KMTS)
Live fair value data for Kestra Medical Technologies, Ltd. Common Stock (KMTS) is currently unavailable. Please check again shortly.
Current Price: $209.00
Valuation: Undervalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Kestra Medical Technologies, Ltd. Common Stock (KMTS) undervalued or overvalued?
Based on the current model output, Kestra Medical Technologies, Ltd. Common Stock appears to be undervalued with a upside of 17.00%.
Fair value vs market price — Kestra Medical Technologies, Ltd. Common Stock (KMTS)
Unlock premium access to view the live fair value comparison against current market price for KMTS.
Frequently Asked Questions - KMTS
How is KMTS intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for KMTS.
Is KMTS undervalued or overvalued right now?
KMTS is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for KMTS: open their intrinsic value pages.